CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 32 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $0 | -100.0% | 49 | -73.5% | 0.00% | – |
| Q3 2021 | $1,000 | -96.8% | 185 | -96.4% | 0.00% | – |
| Q2 2021 | $31,000 | -89.8% | 5,157 | -79.5% | 0.00% | – |
| Q1 2021 | $305,000 | +59.7% | 25,117 | +91.8% | 0.00% | – |
| Q4 2020 | $191,000 | +855.0% | 13,092 | +595.6% | 0.00% | – |
| Q3 2020 | $20,000 | – | 1,882 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,501,716 | $17,284,000 | 8.25% |
| venBio Partners LLC | 3,673,374 | $42,281,000 | 6.42% |
| Omega Fund Management, LLC | 1,335,050 | $15,366,000 | 4.16% |
| Sofinnova Investments, Inc. | 3,606,707 | $41,513,000 | 3.08% |
| Novo Holdings A/S | 2,170,100 | $24,978,000 | 1.24% |
| CLOUGH CAPITAL PARTNERS L P | 1,313,286 | $14,864,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 600,687 | $6,914,000 | 0.59% |
| CAAS CAPITAL MANAGEMENT LP | 44,966 | $518,000 | 0.01% |
| Zimmer Partners, LP | 25,000 | $288,000 | 0.00% |
| Ensign Peak Advisors, Inc | 119,915 | $1,380,000 | 0.00% |